Pharma Archives - World Asthma Foundation

May 26, 2016

Glenmark Pharma launches digital inhaler for asthma patients – Times of India

Glenmark Pharma launches digital inhaler for asthma patients
Times of India
Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, launched what the company touted as India's first Digital Dose Inhaler for asthma and pulmonary disease patients. The inhaler, branded as Digihaler, provides …
Glenmark launches digital dose inhaler for asthma patientsMoneycontrol.com
Glenmark's new 'digital dose inhaler' for asthma, COPD displays dose remaining in itTheHealthSite
Glenmark launches 'Digihaler' for asthma and COPD medicationpharmabiz.com

all 4 news articles »

View full post on asthma – Google News

May 10, 2016

Pharma firms come out with apps for asthma patients – The Hindu

Pharma firms come out with apps for asthma patients
The Hindu
With the number of asthma patients rising by the day, pharmaceutical companies are coming out with mobile apps to connect them with doctors for timely medical help. According to estimates, 50 to 70 per cent of asthma patients in India do not adhere to …
Sun rolls out new app for asthma patientsThe New Indian Express

all 2 news articles »

View full post on asthma – Google News

May 9, 2016

Sun Pharma launches mobile app for asthma patients – Financial Express

ETCIO.com

Sun Pharma launches mobile app for asthma patients
Financial Express
As part of its focus to give boost to treatment compliance amongst Asthma patients by minimising instances of non-adherence and drop-outs in Asthma treatment regime, Sun Pharma Sun Pharma is rolling out India's first unique and innovative mobile …
Sun Pharma's RespiTrack mobile app to boost treatment compliance amongst asthma patientsETCIO.com
Sun Pharma takes mobile app route to raise disease awareness: Abhay GandhiBusiness Standard

all 3 news articles »

View full post on asthma – Google News

April 29, 2016

Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11 – StreetInsider.com

Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11
StreetInsider.com
“The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of asthma …

and more »

View full post on asthma – Google News

January 16, 2016

ALK’s Grazax in five-year landmark asthma prevention trial in children sees … – The Pharma Letter (registration)

ALK's Grazax in five-year landmark asthma prevention trial in children sees …
The Pharma Letter (registration)
Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced disappointing top-line results from the Grazax Asthma Prevention (GAP) trial with ALK's allergy immunotherapy tablet against grass pollen allergy. The GAP trial consisted of a …

View full post on asthma – Google News

December 3, 2015

GSK gets European marketing rights for Nucala to treat asthma – The Pharma Letter (registration)

The Pharma Letter (registration)

GSK gets European marketing rights for Nucala to treat asthma
The Pharma Letter (registration)
UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the …
EU OK for GSK's novel asthma biologicPharmaTimes
Nucala Now Available for Severe AsthmaMonthly Prescribing Reference (registration)
EU Grants Marketing Authorization to GSK's NucalaDrug Discovery & Development
StreetInsider.com –The FINANCIAL –RTT News
all 18 news articles »

View full post on asthma – Google News

December 3, 2015

Ajanta Pharma launches generic asthma treatment tablets in US – Economic Times

Ajanta Pharma launches generic asthma treatment tablets in US
Economic Times
NEW DELHI: Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast …
Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.com
Ajanta Pharma launches anti-asthma tablets in USMyiris.com

all 7 news articles »

View full post on asthma – Google News

November 17, 2015

Ajanta Pharma launches generic asthma drug in US market – ETHealthWorld.com

ETHealthWorld.com

Ajanta Pharma launches generic asthma drug in US market
ETHealthWorld.com
New Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …
Ajanta Pharma launches generic asthma drug in US market; shares up over 2%Daily News & Analysis

all 18 news articles »

View full post on asthma – Google News

November 16, 2015

Ajanta Pharma Launches Generic Asthma Drug in US Market – NDTV

Ajanta Pharma Launches Generic Asthma Drug in US Market
NDTV
New Delhi: Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …

and more »

View full post on asthma – Google News

August 4, 2015